Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has results × Herpes Zoster × Herpes Zoster Vaccine × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Unknown 1 Completed 1

Sponsor Class

INDUSTRY 1 FED 1

Study Type

Interventional 2

Sponsor

Conditions

Herpes Zoster 2 Spondylitis, Ankylosing 1 Psoriasis 1 Crohn Disease 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1 Arthritis 1

Interventions

Herpes Zoster Vaccine 2 Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01767467 2018-06-06

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

GlaxoSmithKline

Phase 3 Completed

568 enrolled 26 charts

Herpes Zoster

NCT02444936 2018-04-06

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Louis Stokes VA Medical Center

Phase 4 Unknown

22 enrolled 8 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon ⚡